Related Experiment Video

Updated: Jul 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

gamma-Tocotrienol inhibits ErbB3-dependent PI3K/Akt mitogenic signalling in neoplastic mammary epithelial cells

G V Samant1, P W Sylvester

  • 1College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209-0470, USA.

Cell Proliferation
|November 18, 2006
PubMed

Insights

Gamma-tocotrienol inhibits neoplastic mammary cell growth by blocking epidermal growth factor signaling. It specifically reduces ErbB3 phosphorylation, which suppresses the PI3K/Akt pathway, thus halting cell proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Neoplastic mammary epithelial cells rely on epidermal growth factor (EGF) signaling for proliferation.
  • The phosphatidylinositol-3-kinase (PI3K)/Akt pathway is a key mitogenic signaling cascade.
  • Gamma-tocotrienol has demonstrated antiproliferative effects in cancer cells.

Purpose of the Study:

  • To investigate the direct effects of gamma-tocotrienol on the PI3K/PDK-1/Akt signaling pathway.
  • To determine the specific molecular targets of gamma-tocotrienol within this pathway.
  • To elucidate the mechanism by which gamma-tocotrienol exerts its antiproliferative effects.

Main Methods:

  • Treatment of +SA mouse mammary epithelial cells with varying concentrations of gamma-tocotrienol.
  • Assessment of cell growth and levels of phosphorylated Akt (active Akt).
  • Enzymatic activity assays for PI3K and Akt.
  • Analysis of ErbB receptor tyrosine phosphorylation, including ErbB1, ErbB2, and ErbB3.

Main Results:

  • Gamma-tocotrienol treatment caused a dose-dependent decrease in +SA cell growth and phospho-Akt levels.
  • No direct inhibition of Akt or PI3K enzymatic activity by gamma-tocotrienol was observed.
  • Gamma-tocotrienol significantly decreased ErbB3 tyrosine phosphorylation, with minimal effect on ErbB1 or ErbB2 phosphorylation.

Conclusions:

  • Gamma-tocotrienol's antiproliferative effects are mediated upstream of PI3K, likely at the EGF receptor level.
  • The mechanism involves the suppression of ErbB3 tyrosine phosphorylation.
  • This suppression leads to reduced PI3K/PDK-1/Akt signaling, ultimately inhibiting neoplastic mammary cell proliferation.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...